Adjuvant radiation therapy after radical prostatectomy: when is it indicated?

Area of Science:

• Oncology
• Urology
• Radiation Oncology

Background:

• Radical prostatectomy is a primary treatment for localized prostate cancer in the US.
• Biochemical recurrence affects up to 30% of patients, increasing mortality risk.
• Current treatments for recurrence include salvage radiation, hormone therapy, or combined approaches.

Purpose of the Study:

• To evaluate the role and efficacy of adjuvant radiation therapy (ART) post-prostatectomy.
• To assess ART's impact on patients with adverse pathological risk factors before recurrence.
• To review evolving evidence from recent randomized trials on ART outcomes.

Main Methods:

• Review of recent randomized trials and long-term prospective studies on adjuvant radiation therapy.
• Analysis of patient outcomes, including overall survival and cancer-specific survival.
• Consideration of pathological characteristics and clinical status for treatment decisions.

Main Results:

• Recent trials indicate ART significantly improves overall and cancer-specific survival.
• ART has been shown to be effective without major adverse effects in select patient groups.
• Evidence supporting ART is strengthening with ongoing long-term trial follow-ups.

Conclusions:

• Adjuvant radiation therapy (ART) shows promise for improving outcomes in prostate cancer patients post-prostatectomy with adverse risk factors.
• The decision to use ART should be individualized, considering patient pathology, clinical status, and potential side effects.
• Open patient-provider communication is crucial for shared decision-making regarding ART.